DK210183D0 - Fremgangsmade til fremstillng af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf - Google Patents
Fremgangsmade til fremstillng af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte derafInfo
- Publication number
- DK210183D0 DK210183D0 DK2101/83A DK210183A DK210183D0 DK 210183 D0 DK210183 D0 DK 210183D0 DK 2101/83 A DK2101/83 A DK 2101/83A DK 210183 A DK210183 A DK 210183A DK 210183 D0 DK210183 D0 DK 210183D0
- Authority
- DK
- Denmark
- Prior art keywords
- piperidinoquinazoline
- preparing
- compounds
- acceptable salts
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8214206 | 1982-05-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK210183D0 true DK210183D0 (da) | 1983-05-11 |
| DK210183A DK210183A (da) | 1983-11-16 |
Family
ID=10530384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK210183A DK210183A (da) | 1982-05-15 | 1983-05-11 | Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4489075A (da) |
| EP (1) | EP0094766B1 (da) |
| JP (1) | JPS58208289A (da) |
| KR (1) | KR840004747A (da) |
| AU (1) | AU538171B2 (da) |
| CA (1) | CA1195977A (da) |
| DD (2) | DD210269A5 (da) |
| DE (1) | DE3368631D1 (da) |
| DK (1) | DK210183A (da) |
| ES (3) | ES522278A0 (da) |
| FI (1) | FI831684L (da) |
| GR (1) | GR77498B (da) |
| IL (1) | IL68668A0 (da) |
| IN (1) | IN160680B (da) |
| NO (1) | NO831728L (da) |
| NZ (1) | NZ204225A (da) |
| PH (1) | PH18763A (da) |
| PL (2) | PL247054A1 (da) |
| PT (1) | PT76687B (da) |
| SU (1) | SU1194257A3 (da) |
| YU (1) | YU105083A (da) |
| ZA (1) | ZA833422B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
| ATE231505T1 (de) * | 1991-03-28 | 2003-02-15 | Eisai Co Ltd | Neue heterocyclische/cyclische amine |
| MX371014B (es) * | 2014-05-15 | 2020-01-10 | Pfizer | Forma cristalina de 6-[(4r)-4-metil-1,2-dióxido-1,2,6-tiadiazinan- 2-il]isoquinolin-1-carbonitrilo. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971783A (en) * | 1973-03-07 | 1976-07-27 | Pfizer Inc. | 4-Aminoquinazoline derivatives as cardiac stimulants |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
-
1983
- 1983-04-27 US US06/489,271 patent/US4489075A/en not_active Expired - Fee Related
- 1983-05-05 EP EP83302529A patent/EP0094766B1/en not_active Expired
- 1983-05-05 DE DE8383302529T patent/DE3368631D1/de not_active Expired
- 1983-05-10 IN IN297/DEL/83A patent/IN160680B/en unknown
- 1983-05-11 DK DK210183A patent/DK210183A/da not_active Application Discontinuation
- 1983-05-11 ES ES522278A patent/ES522278A0/es active Granted
- 1983-05-12 IL IL68668A patent/IL68668A0/xx unknown
- 1983-05-12 YU YU01050/83A patent/YU105083A/xx unknown
- 1983-05-13 GR GR71346A patent/GR77498B/el unknown
- 1983-05-13 CA CA000428080A patent/CA1195977A/en not_active Expired
- 1983-05-13 NZ NZ204225A patent/NZ204225A/en unknown
- 1983-05-13 PH PH28901A patent/PH18763A/en unknown
- 1983-05-13 FI FI831684A patent/FI831684L/fi not_active Application Discontinuation
- 1983-05-13 NO NO831728A patent/NO831728L/no unknown
- 1983-05-13 PL PL24705483A patent/PL247054A1/xx unknown
- 1983-05-13 DD DD83250918A patent/DD210269A5/de unknown
- 1983-05-13 PL PL24196883A patent/PL241968A1/xx unknown
- 1983-05-13 SU SU833597905A patent/SU1194257A3/ru active
- 1983-05-13 DD DD83259680A patent/DD216018A5/de unknown
- 1983-05-13 ZA ZA833422A patent/ZA833422B/xx unknown
- 1983-05-13 AU AU14522/83A patent/AU538171B2/en not_active Ceased
- 1983-05-13 PT PT76687A patent/PT76687B/pt unknown
- 1983-05-14 KR KR1019830002145A patent/KR840004747A/ko not_active Application Discontinuation
- 1983-05-16 JP JP58085660A patent/JPS58208289A/ja active Pending
- 1983-12-28 ES ES528481A patent/ES528481A0/es active Granted
- 1983-12-28 ES ES528482A patent/ES528482A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FI831684A0 (fi) | 1983-05-13 |
| SU1194257A3 (ru) | 1985-11-23 |
| IL68668A0 (en) | 1983-09-30 |
| EP0094766A2 (en) | 1983-11-23 |
| ES8504793A1 (es) | 1985-05-01 |
| EP0094766A3 (en) | 1984-12-12 |
| ES8504794A1 (es) | 1985-05-01 |
| NO831728L (no) | 1983-11-16 |
| DD210269A5 (de) | 1984-06-06 |
| ES528482A0 (es) | 1985-05-01 |
| NZ204225A (en) | 1985-12-13 |
| EP0094766B1 (en) | 1986-12-30 |
| AU1452283A (en) | 1983-11-17 |
| DD216018A5 (de) | 1984-11-28 |
| YU105083A (en) | 1986-02-28 |
| PT76687A (en) | 1983-06-01 |
| GR77498B (da) | 1984-09-24 |
| DE3368631D1 (de) | 1987-02-05 |
| ES8407039A1 (es) | 1984-08-16 |
| IN160680B (da) | 1987-07-25 |
| PL241968A1 (en) | 1984-08-13 |
| DK210183A (da) | 1983-11-16 |
| FI831684L (fi) | 1983-11-16 |
| JPS58208289A (ja) | 1983-12-03 |
| KR840004747A (ko) | 1984-10-24 |
| AU538171B2 (en) | 1984-08-02 |
| PH18763A (en) | 1985-09-20 |
| ES522278A0 (es) | 1984-08-16 |
| CA1195977A (en) | 1985-10-29 |
| PL247054A1 (en) | 1985-03-26 |
| ZA833422B (en) | 1984-02-29 |
| ES528481A0 (es) | 1985-05-01 |
| PT76687B (en) | 1986-03-27 |
| US4489075A (en) | 1984-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK160940C (da) | Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf | |
| DK163359C (da) | Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf | |
| DK28282A (da) | Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf | |
| DK552581A (da) | Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK405881A (da) | Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK155792C (da) | Analogifremgangsmaade til fremstilling af pyrrol-eddikesyreamider eller salte deraf | |
| DK158306C (da) | Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK413883D0 (da) | Fremgangsmade til fremstilling af c-20-modificerede macrolid-derivater eller farmaceutisk acceptable salte deraf | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK358183D0 (da) | Fremgangsmade til fremstilling af alfa-aryl-alkansyrer eller salte deraf | |
| DK98383D0 (da) | Fremgangsmade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK152491C (da) | Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf | |
| DK165983C (da) | Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf | |
| DK210183D0 (da) | Fremgangsmade til fremstillng af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK149823C (da) | Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf | |
| DK224381A (da) | Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf | |
| DK366081A (da) | Fremgangsmaade til fremstilling af diaryl-imidazol-forbindelser eller salte deraf | |
| DK432582A (da) | Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf | |
| DK226883A (da) | Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK109781A (da) | Fremgangsmaade til fremstilling af 7-betaaminoisothiazolylacetamido-3-cephem-4-carboxylsyreforbindelser eller salte deraf | |
| DK186283D0 (da) | Fremgangsmade til fremstilling af imidazoquinoxaliner eller salte deraf | |
| DK499983D0 (da) | Fremgangsmade til fremstilling af 5-phenyl-hydantoin-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK475381A (da) | Fremgangsmaade til fremstilling af carboxamidforbindelser eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |